| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/12/2015 | US20150044197 Antibodies that specifically bind to the epha2 receptor |
| 02/12/2015 | US20150044178 Normalization of culture of corneal endothelial cells |
| 02/12/2015 | US20150044168 Treatment of Multiple Sclerosis With Anti-CD19 Antibody |
| 02/12/2015 | US20150044165 Costimulatory b7-h1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target |
| 02/12/2015 | US20150044164 Methods of Treating Autoimmune Diseases |
| 02/12/2015 | US20150044137 Neutralizing antibodies to hiv-1 and their use |
| 02/12/2015 | US20150044135 Dual function markers for diagnostics and therapeutics for upper gastrointestinal tract precancer |
| 02/12/2015 | US20150044134 Compositions, methods and kits for treatment of cancer and autoimmune diseases |
| 02/12/2015 | DE102007045935B4 Fertilitätstest Fertility Test |
| 02/11/2015 | EP2835648A1 Immunoassay for Phenethylamines of the 2C and DO Sub-Families |
| 02/11/2015 | EP2835644A1 Nanocomposites for encapsulation of cells and method for treating diseases |
| 02/11/2015 | EP2835380A1 Method of blocking vascular leakage using an anti-Ang2 antibody |
| 02/11/2015 | EP2835379A1 Multi-functional antibody polypeptide for cryptic epitope of epidermal growth factor receptor and t cell antigen |
| 02/11/2015 | EP2834273A1 Bispecific antibodies against human tweak and human il17 and uses thereof |
| 02/11/2015 | EP2834272A2 Anti-hla-b*27 antibodies and uses thereof |
| 02/11/2015 | EP2834271A1 Humanized and chimeric anti-factor bb antibodies and uses thereof |
| 02/11/2015 | EP2834270A1 Humanized tau antibody |
| 02/11/2015 | EP2833900A1 Extracellular matrix metalloproteinase inducer (emmprin) peptides and binding antibodies |
| 02/11/2015 | CN104350069A 中和rsv、mpv和pvm的抗体和其应用 And in rsv, mpv and pvm antibodies and their applications |
| 02/11/2015 | CN104350068A 生产型细胞系的增强子 Enhancer production cell lines |
| 02/11/2015 | CN104342455A 表达具有人λ可变区和小鼠恒定区的轻链的小鼠 Expression of mouse having human λ light chain variable region and a mouse constant region |
| 02/11/2015 | CN104342453A 含基因工程抗体基因表达盒的微环dna重组母质粒、含该表达盒的微环dna及应用 Microring dna parent plasmid containing the genetically engineered recombinant antibody gene expression cassette, the expression cassette containing the microring dna and Applications |
| 02/11/2015 | CN104341505A 对蒙古人种和高加索人种低免疫原性的、抗egfr的人鼠嵌合抗体 For Mongoloid and Caucasoid low immunogenicity, anti-human chimeric antibody egfr |
| 02/11/2015 | CN104341504A 双特异性抗体 Bispecific antibody |
| 02/11/2015 | CN104341503A 对蒙古人种和高加索人种低免疫原性的、抗cd20的人抗体 For Mongoloid and Caucasoid low immunogenicity, anti-human antibodies cd20 |
| 02/11/2015 | CN104341502A 低免疫原性抗TNF-α全人源单抗及其应用 Low immunogenicity fully human anti-TNF-α monoclonal antibody and its application |
| 02/11/2015 | CN104341501A 抗IL-1β人源化单克隆抗体及其制备方法和应用 Anti-IL-1β humanized monoclonal antibody and its preparation method and application |
| 02/11/2015 | CN104341500A 螯合淀粉样蛋白β肽的人源化抗体 Human amyloid β peptide chelating humanized antibody |
| 02/11/2015 | CN104341499A 抗麻疹与百白破四价卵黄抗体制剂的制备工艺 Against measles and DPT preparation tetravalent yolk antibody preparations |
| 02/11/2015 | CN104341498A 抗血清、中和抗体、及含其的医药组合物 Antiserum, neutralizing antibodies, and pharmaceutical compositions containing it |
| 02/11/2015 | CN104341409A 一种噻苯咪唑半抗原制备方法及其应用 One kind of thiabendazole hapten preparation method and its application |
| 02/11/2015 | CN104341357A 一种甲氧苄啶半抗原t2制备完全抗原的方法及应用 One kind of trimethoprim hapten t2 complete antigen preparation method and application |
| 02/11/2015 | CN103275227B Axl抗体 Axl antibody |
| 02/11/2015 | CN102827282B 人源抗Trop-2基因工程抗体IgG及其应用 Human anti-Trop-2 antibody IgG and its application of genetic engineering |
| 02/11/2015 | CN102675459B Thp蛋白单克隆抗体的制备方法 Preparation Thp monoclonal antibodies |
| 02/11/2015 | CN101939335B 抗软骨退变的抗原结合多肽 Anti cartilage degeneration antigen binding polypeptide |
| 02/11/2015 | CN101641373B Dkk-1的特异性抗体 Dkk-1 specific antibody of |
| 02/11/2015 | CN101563362B 重组hcv e2糖蛋白 Recombinant glycoproteins hcv e2 |
| 02/10/2015 | US8952215 Antibody-producing transgenic silkworms and methods for producing the same |
| 02/10/2015 | US8952136 Antibodies to human programmed death receptor PD-1 |
| 02/10/2015 | US8952135 S. agalactiae antigens I and II |
| 02/10/2015 | US8952134 Hybrid constant regions |
| 02/10/2015 | US8952132 Engineered immunoglobulin FC polypeptides |
| 02/10/2015 | US8951972 FGFR1 extracellular domain combination therapies for lung cancer |
| 02/10/2015 | US8951959 Glucagon-like peptide-1 analogues and uses thereof |
| 02/10/2015 | US8951793 Method of making an isolated population of FOXP3+ regulatory T cells |
| 02/10/2015 | US8951790 Mammalian expression vector pUHAB |
| 02/10/2015 | US8951755 Products comprising inactivated yeasts or moulds and active VHH-type antibodies |
| 02/10/2015 | US8951747 Method for modulating activity of T lymphocytes |
| 02/10/2015 | US8951744 Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers |
| 02/10/2015 | US8951737 Treatment and diagnosis of cancer |
| 02/10/2015 | US8951542 Lipid vesicle compositions and methods of use |
| 02/10/2015 | US8951531 Modified Streptococcus pneumonia pneumolysin (PLY) polypeptides |
| 02/10/2015 | US8951527 Radioprotectants targeting thrombospondin-1 and CD47 |
| 02/10/2015 | US8951526 Antibody against mucin 1 (MUC1) protein and use of same |
| 02/10/2015 | US8951525 Human tissue factor antibody and uses thereof |
| 02/10/2015 | US8951524 Use of monoclonal antibodies specific to the O-acetylated form of GD2 ganglioside for treatment of certain cancers |
| 02/10/2015 | US8951522 Methods for treating conditions associated with MASP-2 dependent complement activation |
| 02/10/2015 | US8951521 Compounds having activity of suppressing activation of TGF-β receptor, method for screening of the compounds, and composition for preventing or treating disease caused by hepatitis C virus |
| 02/10/2015 | US8951519 Immunotherapy targeting of the shared abnormal conformational state of amyloidogenic peptides/proteins |
| 02/10/2015 | US8951518 Substance specific to human PD-1 |
| 02/10/2015 | US8951517 Identification and engineering of antibodies with variant Fc regions and methods of using same |
| 02/10/2015 | US8951516 Variant immunoglobulins with improved manufacturability |
| 02/10/2015 | CA2764400C Novel centromeric protein shugoshin |
| 02/10/2015 | CA2666607C Method of isolating biomacromolecules using low ph and divalent cations |
| 02/10/2015 | CA2537473C Cytokine involved in epithelial-mesenchymal transition |
| 02/10/2015 | CA2489860C Use of an antibody against s100a8 or s100a9 as chemotactic factor inhibitor for modulating inflammatory reactions |
| 02/05/2015 | WO2015017822A1 Antibodies or fusion proteins multimerized via homomultimerizing peptide |
| 02/05/2015 | WO2015017690A1 Treatment of multiple sclerosis by alemtuzumab induction followed by laquinimod therapy |
| 02/05/2015 | WO2015017683A1 Antimicrobial compositions and methods of use |
| 02/05/2015 | WO2015017600A1 Afucosylated anti-fgfr2iiib antibodies |
| 02/05/2015 | WO2015017576A1 Anti-activin a antibodies and uses thereof |
| 02/05/2015 | WO2015017533A1 Ntrk2 fusions |
| 02/05/2015 | WO2015017528A1 Pik3c2g fusions |
| 02/05/2015 | WO2015017496A1 Methods of selecting biologic-producing cell lines by next generation sequencing |
| 02/05/2015 | WO2015016718A1 Combining cd27 agonists and immune checkpoint inhibition for immune stimulation |
| 02/05/2015 | WO2015016559A1 Anti-egfr antibody and anti-c-met/anti-egfr bispecific antibodies comprising the same |
| 02/05/2015 | WO2015016386A1 Medicament comprising anti-phospholipase d4 antibody |
| 02/05/2015 | WO2015016267A1 Anti-human cd26 monoclonal antibody or antigen-binding fragment thereof |
| 02/05/2015 | WO2015015489A1 Antibody for treating diabetes and autoimmune diseases |
| 02/05/2015 | WO2015015401A2 Anti-cxcr4 antibodies and antibody-drug conjugates |
| 02/05/2015 | WO2015015003A1 Anti-garp protein and uses thereof |
| 02/05/2015 | WO2015014979A1 Tnfa-il-17 bispecific antibodies |
| 02/05/2015 | WO2015014884A1 Therapeutic fusion protein |
| 02/05/2015 | WO2015014659A1 Anti-claudin 1 antibodies and uses thereof |
| 02/05/2015 | WO2015014657A1 Anti-claudin 1 antibodies for use in the treatment of colorectal cancer |
| 02/05/2015 | WO2014190441A9 Heteromultimers with reduced or silenced effector function |
| 02/05/2015 | US20150040254 Porcine CD28 receptor, gene for encoding same, and application of same |
| 02/05/2015 | US20150040252 Novel beta-actin and rps21 promoters and uses thereof |
| 02/05/2015 | US20150040251 Sheep nematode vaccine |
| 02/05/2015 | US20150040250 Animal Models and Therapeutic Molecules |
| 02/05/2015 | US20150038684 Bispecific chimeric antigen receptors and therapeutic uses thereof |
| 02/05/2015 | US20150038683 Methods and compositions for the generation and use of conformation-specific antibodies |
| 02/05/2015 | US20150038682 Antibodies or fusion proteins multimerized via homomultimerizing peptide |
| 02/05/2015 | US20150038366 Immunoassay for Phenethylamines of the 2C and DO Sub-Families |
| 02/05/2015 | US20150037905 Risk markers for cardiovascular disease |
| 02/05/2015 | US20150037886 Treatment drug for autoimmune diseases and allergic diseases |
| 02/05/2015 | US20150037872 Protein Variants Having Modified Immunogenicty |
| 02/05/2015 | US20150037871 Therapeutic nuclease compositions and methods |
| 02/05/2015 | US20150037867 Purification method |